Solid lipid nanoparticles (SLNs) have been proposed in the 1990s as appropriate drug delivery systems, and ever since they have been applied in a wide variety of cosmetic and pharmaceutical applications. In addition, SLNs are considered suitable alternatives as carriers in gene delivery. Although important advances have been made in this particular field, fundamental knowledge of the underlying mechanisms of SLN-mediated gene delivery is conspicuously lacking, an imperative requirement in efforts aimed at further improving their efficiency. Here, we address recent advances in the use of SLNs as platform for delivery of nucleic acids as therapeutic agents. In addition, we will discuss available technology for conveniently producing SLNs. In particular, we will focus on underlying molecular mechanisms by which SLNs and nucleic acids assemble into complexes and how the nucleic acid cargo may be released intracellularly. In discussing underlying mechanisms, we will, when appropriate, refer to analogous studies carried out with systems based on cationic lipids and polymers, that have proven useful in the assessment of structure-function relationships. Finally, we will give suggestions for improving SLN-based gene delivery systems, by pointing to alternative methods for SLNplex assembly, focusing on the realization of a sustained nucleic acid release.201 113Sheridan, C., Gene therapy finds its niche (2011) Nat. Biotechnol., 29, pp. 121-128Wiethoff, C.M., Middaugh, C.R., Barriers to nonviral gene delivery (2003) J. Pharm. Sci., 92, pp. 203-217Zuhorn, I.S., Engberts, J.B.F.N., Hoekstra, D., Gene delivery by cationic lipid vectors: Overcoming cellular barriers (2007) Eur. Biophys. J., 36, pp. 349-362Pérez-Martínez, F.C., Guerra, J., Posadas, I., Ceña, V., Barriers to non-viral vector-mediated gene delivery in the nervous system (2011) Pharm. Res., 28, pp. 1843-1858Manno, C.S., Pierce, G.F., Arruda, V.R., Glader, B., Ragni, M., Rasko, J.J., Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response (2006) Nat. Med., 12, pp. 342-347Mingozzi, F., Meulenberg, J.J., Hui, D.J., Basner-Tschakarjan, E., Hasbrouck, N.C., Edmonson, S.A., AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells (2009) Blood, 114, pp. 2077-2086Sadelain, M., Papapetrou, E.P., Bushman, F.D., Safe harbours for the integration of new DNA in the human genome (2012) Nat. Rev. Cancer, 12, pp. 51-58Pathak, A., Patnaik, S., Gupta, K.C., Recent trends in non-viral vector-mediated gene delivery (2009) Biotechnol. J., 4, pp. 1559-1572Wei, J., Jones, J., Kang, J., Card, A., Krimm, M., Hancock, P., RNA-induced silencing complex-bound small interfering RNA is a determinant of RNA interference-mediated gene silencing in mice (2011) Mol. Pharmacol., 79, pp. 953-963Lobovkina, T.T., Jacobson, G.B.G., Gonzalez-Gonzalez, E.E., Hickerson, R.P.R., Leake, D.D., Kaspar, R.L.R., In vivo sustained release of siRNA from solid lipid nanoparticles (2011) ACS Nano, 5, pp. 9977-9983Goyal, R., Tripathi, S.K., Tyagi, S., Ravi Ram, K., Ansari, K.M., Shukla, Y., Gellan gum blended PEI nanocomposites as gene delivery agents: Evidences from in vitro and in vivo studies (2011) Eur. J. Pharm. Biopharm., 79, pp. 3-14McLachlan, G., Davidson, H., Holder, E., Davies, L.A., Pringle, I.A., Sumner-Jones, S.G., Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung (2011) Gene Ther., 18, pp. 996-1005Ginn, S.L., Alexander, I.E., Edelstein, M.L., Abedi, M.R., Wixon, J., Gene therapy clinical trials worldwide to 2012 - An update (2013) J. Gene Med., 15, pp. 65-77Rehman, Z.U., Zuhorn, I.S., Hoekstra, D., How cationic lipids transfer nucleic acids into cells and across cellular membranes: Recent advances (2013) J. Control. Release, 166, pp. 46-56Hope, M.J., Enhancing siRNA delivery by employing lipid nanoparticles (2014) Ther. Deliv., 5, pp. 663-673Viola, J.R., El Andaloussi, S., Oprea, I.I., Smith, C.I.E., Non-viral nanovectors for gene delivery: Factors that govern successful therapeutics (2010) Expert Opin. Drug Deliv., 7, pp. 721-735Guo, X., Huang, L., Recent advances in nonviral vectors for gene delivery (2012) Acc. Chem. Res., 45, pp. 971-979Cui, H., Feng, Y., Ren, W., Zeng, T., Lv, H., Pan, Y., Strategies of large scale synthesis of monodisperse nanoparticles (2009) Recent Pat. Nanotechnol., 3, pp. 32-41Kim, J., Hwang, I., Britain, D., Chung, T.D., Sun, Y., Kim, D.-H., Microfluidic approaches for gene delivery and gene therapy (2011) Lab Chip, 11, pp. 3941-3948Clement, J., Kiefer, K., Kimpfler, A., Garidel, P., Peschka-Süss, R., Large-scale production of lipoplexes with long shelf-life (2005) Eur. J. Pharm. Biopharm., 59, pp. 35-43Balbino, T.A., Azzoni, A.R., De La Torre, L.G., Microfluidic devices for continuous production of pDNA/cationic liposome complexes for gene delivery and vaccine therapy (2013) Colloids Surf., B, 111 C, pp. 203-210Saranya, N., Moorthi, A., Saravanan, S., Devi, M.P., Selvamurugan, N., Chitosan and its derivatives for gene delivery (2011) Int. J. Biol. Macromol., 48, pp. 234-238Khan, W., Hosseinkhani, H., Ickowicz, D., Hong, P.-D., Yu, D.-S., Domb, A.J., Polysaccharide gene transfection agents (2012) Acta Biomater., 8, pp. 4224-4232Sokolova, V., Epple, M., Inorganic nanoparticles as carriers of nucleic acids into cells (2008) Angew. Chem. Int. Ed. Engl., 47, pp. 1382-1395Chaturvedi, K., Ganguly, K., Kulkarni, A.R., Kulkarni, V.H., Nadagouda, M.N., Rudzinski, W.E., Cyclodextrin-based siRNA delivery nanocarriers: A state-of-the-art review (2011) Expert Opin. Drug Deliv., 8, pp. 1455-1468Ortiz Mellet, C., García Fernández, J.M., Benito, J.M., Cyclodextrin-based gene delivery systems (2011) Chem. Soc. Rev., 40, pp. 1586-1608Laga, R., Carlisle, R., Tangney, M., Ulbrich, K., Seymour, L.W., Polymer coatings for delivery of nucleic acid therapeutics (2012) J. Control. Release, 161, pp. 537-553Elouahabi, A., Ruysschaert, J., Formation and intracellular trafficking of lipoplexes and polyplexes (2005) Mol. Ther., 11, pp. 336-347Torchilin, V.P., Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery (2008) Biopolymers, 90, pp. 604-610Bolhassani, A., Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer (2011) Biochim. Biophys. Acta, 1816, pp. 232-246Ruozi, B., Forni, F., Battini, R., Vandelli, M.A., Cationic liposomes for gene transfection (2003) J. Drug Target., 11, pp. 407-414Zhou, H.-S., Liu, D.-P., Liang, C.-C., Challenges and strategies: The immune responses in gene therapy (2004) Med. Res. Rev., 24, pp. 748-761Bondi, M.L., Craparo, E.F., Solid lipid nanoparticles for applications in gene therapy: A review of the state of the art (2010) Expert Opin. Drug Deliv., 7, pp. 7-18Bunjes, H., Lipid nanoparticles for the delivery of poorly water-soluble drugs (2010) J. Pharm. Pharmacol., 62, pp. 1637-1645Wissing, S.A., Kayser, O., Müller, R.H., Solid lipid nanoparticles for parenteral drug delivery (2004) Adv. Drug Deliv. Rev., 56, pp. 1257-1272Blasi, P.P., Giovagnoli, S.S., Schoubben, A.A., Ricci, M.M., Rossi, C.C., Solid lipid nanoparticles for targeted brain drug delivery (2007) Adv. Drug Deliv. Rev., 59, pp. 454-477Muchow, M., Maincent, P., Müller, R.H., Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery (2008) Drug Dev. Ind. Pharm., 34, pp. 1394-1405Manjunath, K., Reddy, J.S., Venkateswarlu, V., Solid lipid nanoparticles as drug delivery systems (2005) Methods Find. Exp. Clin. Pharmacol., 27, pp. 127-144Müller, R.H., Mäder, K., Gohla, S., Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of the art (2000) Eur. J. Pharm. Biopharm., 50, pp. 161-177Du Plessis, L.H., Marais, E.B., Mohammed, F., Kotze, A.F., Applications of lipid based formulation technologies in the delivery of biotechnology-based therapeutics (2014) Curr. Pharm. Biotechnol., 15, pp. 659-672Olbrich, C., Bakowsky, U., Lehr, C.M., Müller, R.H., Kneuer, C., Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA (2001) J. Control. Release, 77, pp. 345-355De Jesus, M.B., Radaic, A., Zuhorn, I.S., Paula, E., Microemulsion extrusion technique: A new method to produce lipid nanoparticles (2013) J. Nanopart. Res., 15, pp. 1-15Yu, Y.H., Kim, E., Park, D.E., Shim, G., Lee, S., Kim, Y.B., Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA (2012) Eur. J. Pharm. Biopharm., 80, pp. 268-273Patel, S., Chavhan, S., Soni, H., Babbar, A.K., Mathur, R., Mishra, A.K., Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route (2010) J. Drug Target.Yu, W., Liu, C., Ye, J., Zou, W., Zhang, N., Xu, W., Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery (2009) Nanotechnology, 20, p. 215102Garud, A., Singh, D., Garud, N., Solid lipid nanoparticles (SLN): Method, characterization and applications (2012) Int. Curr. Pharm. J., 1, pp. 384-393Tabatt, K., Sameti, M., Olbrich, C., Müller, R.H., Lehr, C.-M., Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer (2004) Eur. J. Pharm. Biopharm., 57, pp. 155-162Jenning, V., Thünemann, A.F., Gohla, S.H., Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids (2000) Int. J. Pharm., 199, pp. 167-177Jenning, V., Gohla, S., Comparison of wax and glyceride solid lipid nanoparticles (SLN) (2000) Int. J. Pharm., 196, pp. 219-222Freitas, C., Müller, R.H., Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase (1999) Eur. J. Pharm. Biopharm., 47, pp. 125-132Bunjes, H., Koch, M.H.J., Westesen, K., Influence of emulsifiers on the crystallization of solid lipid nanoparticles (2003) J. Pharm. Sci., 92, pp. 1509-1520Mehnert, W., Mäder, K., Solid lipid nanoparticles: Production, characterization and applications (2001) Adv. Drug Deliv. Rev., 47, pp. 165-196Attama, A.A., SLN, NLC, LDC: State of the art in drug and active delivery (2011) Recent Pat. Drug Deliv. Formul., 5, pp. 178-187Tros De Ilarduya, C., Sun, Y., Düzgüneş, N., Gene delivery by lipoplexes and polyplexes (2010) Eur. J. Pharm. Sci., 40, pp. 159-170Parhi, R., Suresh, P., Preparation and characterization of solid lipid nanoparticles - A review (2012) Curr. Drug Discov. Technol., 9, pp. 2-16Corrias, F., Lai, F., New methods for lipid nanoparticles preparation (2011) Recent Pat. Drug Deliv. Formul., 5, pp. 201-213Souto, E.B., Severino, P., Santana, M.H.A., Pinho, S.C., Solid lipid nanoparticles: Classical methods of lab production (2011) Quim. Nova, 34, pp. 1762-1769Radomska-Soukharev, A., Stability of lipid excipients in solid lipid nanoparticles (2007) Adv. Drug Deliv. Rev., 59, pp. 411-418Gasco, M.R., (1993) Method for Producing Solid Lipid Microspheres Having A Narrow Size Distribution, , 5250236Muller, R., Lucks, J., (1996) Arzneistoffträger Aus Festen Lipid Teilchen - Feste Lipid Nanosphären (SLN), , EP 0605497Jiang, Z., Sun, C., Yin, Z., Zhou, F., Ge, L., Liu, X., Comparison of two kinds of nanomedicine for targeted gene therapy: Premodified or postmodified gene delivery systems (2012) Int. J. Nanomedicine, 7, pp. 2019-2031Müller, R.H., Shegokar, R., Keck, C.M., 20 years of lipid nanoparticles (SLN and NLC): Present state of development and industrial applications (2011) Curr. Drug Discov. Technol., 8, pp. 207-227Tabatt, K., Kneuer, C., Sameti, M., Olbrich, C., Müller, R.H., Lehr, C.-M., Transfection with different colloidal systems: Comparison of solid lipid nanoparticles and liposomes (2004) J. Control. Release, 97, pp. 321-332Dingler, A., Gohla, S., Production of solid lipid nanoparticles (SLN): Scaling up feasibilities (2002) J. Microencapsul., 19, pp. 11-16Battaglia, L.S., Cavalli, R., Trotta, M., (2008) Method for the Preparation of Solid Lipid Micro and Nanoparticles, , WO2008149215A2Zhang, Yun, Shen, Chen, Yao, Chen, Formation of solid lipid nanoparticles in a microchannel system with a cross-shaped junction (2008) Chem. Eng. Sci., 63, pp. 5600-5605Balbino, T.A., Aoki, N.T., Gasperini, A.A.M., Oliveira, C.L.P., Azzoni, A.R., Cavalcanti, L.P., Continuous flow production of cationic liposomes at high lipid concentration in microfluidic devices for gene delivery applications (2013) Chem. Eng. J., 226, pp. 423-433Bae, Y.H., Park, K., Targeted drug delivery to tumors: Myths, reality and possibility (2011) J. Control. Release, 153, pp. 198-205Del Pozo-Rodríguez, A., Delgado, D., Solinís, M.A., Gascón, A.R., Pedraz, J.L., Solid lipid nanoparticles: Formulation factors affecting cell transfection capacity (2007) Int. J. Pharm., 339, pp. 261-268Kim, H.R., Kim, I.K., Bae, K.H., Lee, S.H., Lee, Y., Park, T.G., Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA (2008) Mol. Pharm., 5, pp. 622-631Carrillo, C., Sánchez-Hernández, N., García-Montoya, E., Pérez-Lozano, P., Suñé-Negre, J.M., Ticó, J.R., DNA delivery via cationic solid lipid nanoparticles (SLNs) (2013) Eur. J. Pharm. Sci., 49, pp. 157-165Jores, K., Mehnert, W., Drechsler, M., Bunjes, H., Johann, C., Mäder, K., Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy (2004) J. Control. Release, 95, pp. 217-227De Jesus, M.B., Radaic, A., Hinrichs, W.L.J., Ferreira, C.V., De Paula, E., Hoekstra, D., Inclusion of the helper lipid dioleoyl-phosphatidylethanolamine in solid lipid nanoparticles inhibits their transfection efficiency (2014) J. Biomed. Nanotechnol., 10, pp. 355-365Yu, W., Liu, C., Liu, Y., Zhang, N., Xu, W., Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages (2010) Pharm. Res., 27, pp. 1584-1596Vighi, E., Ruozi, B., Montanari, M., Battini, R., Leo, E., PDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles (2010) Int. J. Pharm., 389, pp. 254-261Montana, G., Bondi, M.L., Carrotta, R., Picone, P., Craparo, E.F., San Biagio, P.L., Employment of cationic solid-lipid nanoparticles as RNA carriers (2007) Bioconjug. Chem., 18, pp. 302-308Souto, E.B., Almeida, A.J., Müller, R.H., Lipid nanoparticles (SLN, NLC) for cutaneous drug delivery: Structure, protection and skin effects (2007) J. Biomed. Nanotechnol., 3, pp. 317-331Vighi, E.E., Leot, E.E., Montanari, M.M., Mucci, A.A., Hanuskova, M.M., Iannuccelli, V.V., Structural investigation and intracellular trafficking of a novel multicomposite cationic solid lipid nanoparticle platform as a pDNA carrier (2011) Ther. Deliv., 2, pp. 1419-1435Jenning, V., Mäder, K., Gohla, S.H., Solid lipid nanoparticles (SLN) based on binary mixtures of liquid and solid lipids: A (1)H-NMR study (2000) Int. J. Pharm., 205, pp. 15-21Garcia-Fuentes, M., Alonso, M.J., Torres, D., Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures (2005) J. Colloid Interface Sci., 285, pp. 590-598Pietkiewicz, J., Sznitowska, M., Placzek, M., The expulsion of lipophilic drugs from the cores of solid lipid microspheres in diluted suspensions and in concentrates (2006) Int. J. Pharm., 310, pp. 64-71Karmali, P.P., Chaudhuri, A., Cationic liposomes as non-viral carriers of gene medicines: Resolved issues, open questions, and future promises (2007) Med. Res. Rev., 27, pp. 696-722Wasungu, L., Hoekstra, D., Cationic lipids, lipoplexes and intracellular delivery of genes (2006) J. Control. Release, 116, pp. 255-264Spink, C.H., Chaires, J.B., Thermodynamics of the binding of a cationic lipid to DNA (1997) J. Am. Chem. Soc., 119, pp. 10920-10928Bruinsma, R., Electrostatics of DNA-cationic lipid complexes: Isoelectric instability (1998) Eur. Phys. J. e Soft Matter, 4, pp. 75-88Harries, D., May, S., Gelbart, W.M., Ben-Shaul, A., Structure, stability, and thermodynamics of lamellar DNA-lipid complexes (1998) Biophys. J., 75, pp. 159-173Zuidam, N.J., Hirsch-Lerner, D., Margulies, S., Barenholz, Y., Lamellarity of cationic liposomes and mode of preparation of lipoplexes affect transfection efficiency (1999) Biochim. Biophys. Acta, 1419, pp. 207-220Kennedy, M.T., Pozharski, E.V., Rakhmanova, V.A., Macdonald, R.C., Factors governing the assembly of cationic phospholipid-DNA complexes (2000) Biophys. J., 78, pp. 1620-1633Barreleiro, P.C.A., Olofsson, G., Alexandridis, P., Interaction of DNA with cationic vesicles: A calorimetric study (2000) J. Phys. Chem. B, 104, pp. 7795-7802Wagner, K., Harries, D., May, S., Kahl, V., Rädler, J.O., Ben-Shaul, A., Direct evidence for counterion release upon cationic lipid-DNA condensation (2000) Langmuir, 16, pp. 303-306Matulis, D., Rouzina, I., Bloomfield, V.A., Thermodynamics of cationic lipid binding to DNA and DNA condensation: Roles of electrostatics and hydrophobicity (2002) J. Am. Chem. Soc., 124, pp. 7331-7342Eastman, S.J., Siegel, C., Tousignant, J., Smith, A.E., Cheng, S.H., Scheule, R.K., Biophysical characterization of cationic lipid: DNA complexes (1997) Biochim. Biophys. Acta, 1325, pp. 41-62Pozharski, E., Macdonald, R.C., Lipoplex thermodynamics: Determination of DNA-cationic lipoid interaction energies (2003) Biophys. J., 85, pp. 3969-3978Shirahama, K., Takashima, K., Takisawa, N., Interaction between dodecyltrimethylammonium chloride and DNA (1987) Bull. Chem. Soc. Jpn, 60, pp. 43-47Hirsch-Lerner, D., Barenholz, Y., Hydration of lipoplexes commonly used in gene delivery: Follow-up by laurdan fluorescence changes and quantification by differential scanning calorimetry (1999) Biochim. Biophys. Acta, 1461, pp. 47-57Lazaridis, T., (2013) Hydrophobic Effect, , John Wiley & Sons, LtdOberle, V., Bakowsky, U., Zuhorn, I.S., Hoekstra, D., Lipoplex formation under equilibrium conditions reveals a three-step mechanism (2000) Biophys. J., 79, pp. 1447-1454Ma, B., Zhang, S., Jiang, H., Zhao, B., Lv, H., Lipoplex morphologies and their influences on transfection efficiency in gene delivery (2007) J. Control. Release, 123, pp. 184-194Braun, C.S., Jas, G.S., Choosakoonkriang, S., Koe, G.S., The structure of DNA within cationic lipid/DNA complexes (2003) Biophys. J., 84, pp. 1114-1123Kikuchi, I.S., Carmona-Ribeiro, A.M., Interactions between DNA and synthetic cationic liposomes (2000) J. Phys. Chem. B, 104, pp. 2829-2835Pector, V., Backmann, J., Maes, D., Vandenbranden, M., Ruysschaert, J.M., Biophysical and structural properties of DNA.diC(14)-amidine complexes. Influence of the DNA/lipid ratio (2000) J. Biol. Chem., 275, pp. 29533-29538Gershon, H., Ghirlando, R., Guttman, S.B., Minsky, A., Mode of formation and structural features of DNA-cationic liposome complexes used for transfection (1993) Biochemistry, 32, pp. 7143-7151Sternberg, B., Sorgi, F.L., Huang, L., New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy (1994) FEBS Lett., 356, pp. 361-366Lasic, D.D., Strey, H., Stuart, M.C.A., Podgornik, R., Frederik, P.M., The structure of DNA-liposome complexes (1997) J. Am. Chem. Soc., 119, pp. 832-833Smisterová, J., Wagenaar, A., Stuart, M.C., Polushkin, E., Ten Brinke, G., Hulst, R., Molecular shape of the cationic lipid controls the structure of cationic lipid/dioleylphosphatidylethanolamine-DNA complexes and the efficiency of gene delivery (2001) J. Biol. Chem., 276, pp. 47615-47622Rädler, J.O., Koltover, I., Salditt, T., Safinya, C.R., Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes (1997) Science, 275, pp. 810-814Barreleiro, P.C.A., May, R.P., Lindman, B.R., Mechanism of formation of DNA-cationic vesicle complexes (2002) Faraday Discuss., 122, pp. 191-201Koltover, I., Salditt, T., Rädler, J.O., Safinya, C.R., An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery (1998) Science, 281, pp. 78-81Rakhmanova, V.A., McIntosh, T.J., Macdonald, R.C., Effects of dioleoylphosphatidylethanolamine on the activity and structure of O-alkyl phosphatidylcholine-DNA transfection complexes (2000) Cell. Mol. Biol. Lett., 5, pp. 51-66Safinya, C.R., Structures of lipid-DNA complexes: Supramolecular assembly and gene delivery (2001) Curr. Opin. Struct. Biol., 11, pp. 440-448Rullaud, V., Siragusa, M., Cumbo, A., Gygax, D., Shahgaldian, P., DNA surface coating of calixarene-based nanoparticles: A sequence-dependent binding mechanism (2012) Chem. Commun., 48, pp. 12186-12188Helttunen, K., Shahgaldian, P., Self-assembly of amphiphilic calixarenes and resorcinarenes in water (2010) New J. Chem., 34, pp. 2704-2714Ye, J., Wang, A., Liu, C., Chen, Z., Zhang, N., Anionic solid lipid nanoparticles supported on protamine/DNA complexes (2008) Nanotechnology, 19, p. 285708Doktorovova, S., Shegokar, R., Rakovsky, E., Gonzalez-Mira, E., Lopes, C.M., Silva, A.M., Cationic solid lipid nanoparticles (cSLN): Structure, stability and DNA binding capacity correlation studies (2011) Int. J. Pharm., 420, pp. 341-349Asasutjarit, R., Lorenzen, S.-I., Sirivichayakul, S., Ruxrungtham, K., Ruktanonchai, U., Ritthidej, G.C., Effect of solid lipid nanoparticles formulation compositions on their size, zeta potential and potential for in vitro pHIS-HIV-hugag transfection (2007) Pharm. Res., 24, pp. 1098-1107Moghaddam, B., McNeil, S.E., Zheng, Q., Mohammed, A.R., Perrie, Y., Exploring the correlation between lipid packaging in lipoplexes and their transfection efficacy (2011) Pharmaceutics, 3, pp. 848-864Minchin, R.F., Yang, S., Endosomal disruptors in non-viral gene delivery (2010) Expert Opin. Drug Deliv., 7, pp. 331-339Varkouhi, A.K., Scholte, M., Storm, G., Haisma, H.J., Endosomal escape pathways for delivery of biologicals (2011) J. Control. Release, 151, pp. 220-228Liang, W., Lam, J.K.W., Endosomal escape pathways for non-viral nucleic acid delivery systems (2012) Intechopen.comRehman, Z.U., Hoekstra, D., Zuhorn, I.S., On the mechanism of polyplex- and lipoplex-mediated delivery of nucleic acids: Real-time visualization of transient membrane destabilization without endosomal lysis (2013) ACS NanoBehr, J.-P., The proton sponge: A trick to enter cells the viruses did not exploit (1997) Chimia, 51, pp. 1-2Benjaminsen, R.V., Mattebjerg, M.A., Henriksen, J.R., Moghimi, S.M., Andresen, T.L., The possible "proton sponge" effect of polyethylenimine (PEI) does not include change in lysosomal pH (2013) Mol. Ther., 21, pp. 149-157Pinnaduwage, P., Schmitt, L., Huang, L., Use of a quaternary ammonium detergent in liposome mediated DNA transfection of mouse L-cells (1989) Biochim. Biophys. Acta, 985, pp. 33-37Farhood, H., Serbina, N., Huang, L., The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer (1995) Biochim. Biophys. Acta, 1235, pp. 289-295Zelphati, O., Szoka, F., Mechanism of oligonucleotide release from cationic liposomes (1996) Proc. Natl. Acad. Sci. U. S. A., 93, pp. 11493-11498Lee, E.R., Marshall, J., Siegel, C.S., Jiang, C., Yew, N.S., Nichols, M.R., Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung (1996) Hum. Gene Ther., 7, pp. 1701-1717Mok, K.W., Cullis, P.R., Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA (1997) Biophys. J., 73, pp. 2534-2545Zuhorn, I.S., Bakowsky, U., Polushkin, E., Visser, W.H., Stuart, M.C.A., Engberts, J.B.F.N., Nonbilayer phase of lipoplex-membrane mixture determines endosomal escape of genetic cargo and transfection efficiency (2005) Mol. Ther., 11, pp. 801-810Wrobel, I., Collins, D., Fusion of cationic liposomes with mammalian cells occurs after endocytosis (1995) Biochim. Biophys. Acta, 1235, pp. 296-304Hafez, I.M., Cullis, P.R., Roles of lipid polymorphism in intracellular delivery (2001) Adv. Drug Deliv. Rev., 47, pp. 139-148Shi, F., Wasungu, L., Nomden, A., Stuart, M.C.A., Polushkin, E., Engberts, J.B.F.N., Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotidesRole of lipid exchangeability and non-lamellar transitions (2002) Biochem. J., 366, pp. 333-341Choi, S.H., Jin, S.-E., Lee, M.-K., Lim, S.-J., Park, J.-S., Kim, B.-G., Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells (2008) Eur. J. Pharm. Biopharm., 68, pp. 545-554Rudolph, C., Schillinger, U., Ortiz, A., Tabatt, K., Plank, C., Müller, R.H., Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo (2004) Pharm. Res., 21, pp. 1662-1669Delgado, D., Del Pozo-Rodríguez, A., Solinís M.Á., Rodríguez-Gascón, A., Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: The importance of the entry pathway (2011) Eur. J. Pharm. Biopharm., 79, pp. 495-502Olbrich, C.C., Müller, R.H.R., Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures (1999) Int. J. Pharm., 180, pp. 31-39Xue, H.-Y., Wong, H.-L., Tailoring nanostructured solid-lipid carriers for time-controlled intracellular siRNA kinetics to sustain RNAi-mediated chemosensitization (2011) Biomaterials, 32, pp. 2662-2672Del Pozo-Rodríguez, A., Delgado, D., Solinís M.Á., Pedraz, J.L., Echevarría, E., Rodríguez, J.M., Solid lipid nanoparticles as potential tools for gene therapy: In vivo protein expression after intravenous administration (2010) Int. J. Pharm., 385, pp. 157-162Leung, A.K.K., Hafez, I.M., Baoukina, S., Belliveau, N.M., Zhigaltsev, I.V., Afshinmanesh, E., Lipid nanoparticles containing siRNA synthesized by microfluidic mixing exhibit an electron-dense nanostructured core (2012) J. Phys. Chem. C Nanomater. Interfaces, 116, pp. 18440-18450Bunjes, H., Drechsler, M., Koch, M.H., Westesen, K., Incorporation of the model drug ubidecarenone into solid lipid nanoparticles (2001) Pharm. Res., 18, pp. 287-293Hayes, M.E., Drummond, D.C., Hong, K., Park, J.W., Marks, J.D., Kirpotin, D.B., Assembly of nucleic acid-lipid nanoparticles from aqueous-organic monophases (2006) Biochim. Biophys. Acta, 1758, pp. 429-442Severino, P., Pinho, S.C., Souto, E.B., Santana, M.H.A., Polymorphism, crystallinity and hydrophilic-lipophilic balance of stearic acid and stearic acid-capric/caprylic triglyceride matrices for production of stable nanoparticles (2011) Colloids Surf., B, 86, pp. 125-130Kuo, Y.-C., Wang, C.-C., Electrophoresis of human brain microvascular endothelial cells with uptake of cationic solid lipid nanoparticles: Effect of surfactant composition (2010) Colloids Surf., B, 76, pp. 286-291Griffin, W.C., Classification of surface-active agents by "hLB" (1949) J. Soc. Cosmet. Chem., 1, pp. 311-326Heurtault, B., Saulnier, P., Pech, B., Proust, J.-E., Benoit, J.-P., Physico-chemical stability of colloidal lipid particles (2003) Biomaterials, 24, pp. 4283-4300Gasco, M.R., Lipid nanoparticles: Perspectives and challenges (2007) Adv. Drug Deliv. Rev., 59, pp. 377-378Liu, Z., Zhong, Z., Peng, G., Wang, S., Du, X., Yan, D., Folate receptor mediated intracellular gene delivery using the charge changing solid lipid nanoparticles (2009) Drug Deliv., 16, pp. 341-347Seetapan, N., Bejrapha, P., Srinuanchai, W., Ruktanonchai, U.R., Rheological and morphological characterizations on physical stability of gamma-oryzanol-loaded solid lipid nanoparticles (SLNs) (2010) Micron, 41, pp. 51-58Vighi, E., Ruozi, B., Montanari, M., Battini, R., Leo, E., Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: Characterization and ability to bind the pEGFP-plasmid (2007) Eur. J. Pharm. Biopharm., 67, pp. 320-328Abdelwahed, W., Degobert, G., Stainmesse, S., Fessi, H., Freeze-drying of nanoparticles: Formulation, process and storage considerations (2006) Adv. Drug Deliv. Rev., 58, pp. 1688-1713Del Pozo-Rodríguez, A., Solinís, M.A., Gascón, A.R., Pedraz, J.L., Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy (2009) Eur. J. Pharm. Biopharm., 71, pp. 181-189Poxon, S.W., Hughes, J.A., The effect of lyophilization on plasmid DNA activity (2000) Pharm. Dev. Technol., 5, pp. 115-122Heiati, H., Tawashi, R., Phillips, N.C., Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization (1998) J. Microencapsul., 15, pp. 173-184Chollet, P., Favrot, M.C., Hurbin, A., Coll, J.-L., Side-effects of a systemic injection of linear polyethylenimine-DNA complexes (2002) J. Gene Med., 4, pp. 84-91